M6P Therapeutics
生物技术研究
St Louis，Missouri 571 位关注者
Next generation enzyme replacement and gene therapies for rare diseases.
关于我们
M6P Therapeutics is developing the next-generation enzyme replacement and gene therapies for lysosomal storage disorders. We have discovered a novel method for significantly increasing mannose-6-phosphate phosphorylation of various lysosomal enzymes. This allows for markedly improved enzyme delivery to target tissues and promises improved clinical outcomes.
- 网站
-
https://www.m6ptherapeutics.com
M6P Therapeutics的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- St Louis，Missouri
- 类型
- 私人持股
- 创立
- 2017
地点
-
主要
获取路线
20 S Sarah St
US，Missouri，St Louis，63108
M6P Therapeutics员工
-
Gavin Maitland
Owner at Fleming CFO
-
Steve Walker
Laboratory Manager at M6P Therapeutics, Inc. - Purchasing, Shipping/Receiving, Inventory Control, Equipment Management
-
Catherine Foulon
President and Lead Reg-CMC Consultant at Centaurus Consulting Group, LLC
-
Russell Gotschall
Vice President, R&D at M6P Therapeutics